Your browser doesn't support javascript.
loading
Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation.
Rosas, Melissa M; Sobieszczyk, Michal J; Warren, Whittney; Mason, Phillip; Walter, Robert J; Marcus, Joseph E.
Afiliación
  • Rosas MM; Pulmonary and Critical Care Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
  • Sobieszczyk MJ; Pulmonary and Critical Care Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
  • Warren W; Pulmonary and Critical Care Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
  • Mason P; Critical Care Division, Emergency Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
  • Walter RJ; Pulmonary and Critical Care Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
  • Marcus JE; Infectious Disease Division, Department of Medicine, Brooke Army Medical Center, Joint Base San Antonio, Texas, USA.
Open Forum Infect Dis ; 9(8): ofac374, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35949400
ABSTRACT
There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...